A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Hydrocodone Bitartrate (Hysingla ER)

First FDA approval2015-01-15
Generic availableYes · 1 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$30.3M in CY2024 Part D spend53K claims · 11K beneficiaries · 329 plans surveyed

Lowest NADAC
$8.02/unit
6 NDCs benchmarked, lowest of all strengths.
Average NADAC
$25.30
Across all dosage forms in distribution.
Highest NADAC
$48.66
Wide spread — brand-strength NDCs still in market.
Plans with PA
418 / 329
Limited PA friction.

Questions a plan sponsor actually asks.

FAQPage schema10 entries indexed · 4 visible
What is Hydrocodone Bitartrate used for?

Hydrocodone Bitartrate is a this drug class medication tracked in Medicare Part D.

Is there a generic for Hydrocodone Bitartrate?

Yes. 13 ANDAs filed at FDA, 1 generic manufacturers currently shipping.

How much does my plan pay for Hydrocodone Bitartrate?

Across 329 Part D plans, Hydrocodone Bitartrate averages $25.30/unit (NADAC). Lowest available: $8.02/unit. Highest in distribution: $48.66/unit.

Is Hydrocodone Bitartrate on the FDA shortage list?

No. Hydrocodone Bitartrate is not currently on the FDA Drug Shortage Database.

6 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (6 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.